Exor N.V.
- SEC CIK
- 0001589122
- Latest filing
- Aug 3, 2026
The latest 13F from Exor N.V. covers Q2 2026 (filed Aug 3, 2026): 3 long positions worth $5.46B. The top 10 holdings make up 100.0% of the portfolio, and the largest is 0 at 92.6%. Livermore has 15 filings on Form 13F from this institution, going back to Q4 2022.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 1
- Est. +$92.1M
- Reduced
- 0
- Sold out
- 0
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- 0000000000+$92.1MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
None this quarter.
Biggest sells
Reduced and sold-out positions, by estimated amount sold
None this quarter.
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
None this quarter.
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $5.46B
- +$73.2M (+1.4%) vs. prior quarter
- Positions
- 3
- 0 vs. prior quarter
- Top 10 concentration
- 100.0%
- Top 10 as share of value
- Turnover
- 0.0%
- Q2 2026, one quarter
- Average holding period
- 12.6 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.
13F filings by quarter
15 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $5.91B (Q3 2025)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | 3 | $5.46B | 0VIACLVT | vs. Q1 2026 | SEC |
| Q1 2026 | May 13, 2026 | 3 | $5.38B | 0VIACLVT | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 3, 2026 | 3 | $5.58B | 0VIACLVT | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 12, 2025 | 3 | $5.91B | 0VIACLVT | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 16, 2025 | 2 | $4.67B | 0CLVT | vs. Q1 2025 | SEC |
| Q1 2025 | May 8, 2025 | 2 | $4.65B | 0CLVT | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 22, 2025 | 2 | $4.51B | 0CLVT | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 17, 2024 | 2 | $5.86B | 0CLVT | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 9, 2024 | 2 | $4.53B | 0CLVT | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 16, 2024 | 2 | $3.29B | 0CLVT | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 12, 2024 | 2 | $3.86B | 0CLVT | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 8, 2023 | 2 | $3.00B | 0CLVT | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 2 | $905.4M | 0CLVT | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 1 | $304.9M | CLVT | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 1 | $139.0M | CLVT | – | SEC |
13D and 13G filings
Companies where Exor N.V. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
4 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| RACEFerrari N.V. | 13D/A | 21.30%37.8M shares | −10.50 ppfrom 31.80% | Dec 19, 20224 filings | Jan 6, 2026 | SEC |
| PHGKoninklijke Philips NV | 13D/A | 19.03%185.9M shares | +0.33 ppfrom 18.70% | Aug 23, 20235 filings | Aug 21, 2026 | SEC |
| VIAVia Transportation, Inc. | 13G | 18.60%14.1M shares | New | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| VALValaris Ltd | 13G | 5.10%3.64M shares | New | Jan 13, 20251 filing | Jan 13, 2025 | SEC |
Latest filings
41 filings on file made by Exor N.V. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|---|
| MOHMolina Healthcare, Inc. | Sep 3, 20269:15 AM ET | Exor Capital LLPand 3 others | 13G | 5.21%2.72M shares | New | Aug 28, 2026 | SEC |
| PHGKoninklijke Philips NV | Aug 21, 20263:03 PM ET | Exor N.V.and 1 other | 13D/A | 19.03%185.9M shares | +0.33 ppfrom 18.70% | Aug 10, 2026 | SEC |
| VALValaris Ltd | Aug 10, 20269:30 AM ET | Exor Capital LLPand 3 others | 13G/A | 3.48%2.41M shares | –Below 5% | Jun 30, 2026 | SEC |
| VEONVEON Ltd. | Aug 10, 20269:05 AM ET | Exor Capital LLPand 3 others | 13G/A | 7.12%131.6M shares | −1.62 ppfrom 8.74% | Jun 30, 2026 | SEC |
| SBSWSibanye Stillwater Ltd | May 15, 20269:13 AM ET | Exor Capital LLPand 3 others | 13G/A | 5.32%150.7M shares | – | Mar 31, 2026 | SEC |
| RACEFerrari N.V. | Jan 6, 20264:40 PM ET | Exor N.V.and 4 others | 13D/A | 21.30%37.8M shares | −10.50 ppfrom 31.80% | Jan 3, 2026 | SEC |
| VEONVEON Ltd. | Nov 14, 202510:18 AM ET | Exor Capital LLPand 3 others | 13G/A | 8.74%151.1M shares | – | Sep 30, 2025 | SEC |
| VIAVia Transportation, Inc. | Nov 13, 20253:25 PM ET | Exor N.V.and 1 other | 13G | 18.60%14.1M shares | New | Sep 30, 2025 | SEC |
| NGNovagold Resources Inc | Aug 11, 202510:22 AM ET | Exor Capital LLPand 3 others | 13G | 8.58%34.9M shares | New | Jun 30, 2025 | SEC |
| PHGKoninklijke Philips NV | Mar 18, 20255:04 PM ET | Exor N.V.and 1 other | 13D/A | 18.70%172.8M shares | – | Mar 15, 2025 | SEC |
| RACEFerrari N.V. | Mar 5, 202512:48 PM ET | Exor N.V.and 4 others | 13D/A | 31.80%56.7M shares | −3.60 ppfrom 35.40% | Mar 5, 2025 | SEC |
| RACEFerrari N.V. | Feb 27, 20255:08 PM ET | Exor N.V.and 4 others | 13D/A | 35.40%63.3M shares | – | Feb 27, 2025 | SEC |
| VALValaris Ltd | Jan 13, 202511:24 AM ET | Exor N.V.and 3 others | 13G | 5.10%3.64M shares | New | Oct 31, 2024 | SEC |
| SBSWSibanye Stillwater Ltd | Nov 13, 2024 | Exor N.V. | 13G/AOld format | – | – | – | SEC |
| NGNovagold Resources Inc | Nov 13, 2024 | Exor N.V. | 13G/AOld format | – | – | – | SEC |
| PHGKoninklijke Philips NV | Jun 25, 2024 | Exor N.V. | 13D/AOld format | – | – | – | SEC |
| GATOGatos Silver, Inc. | Jun 4, 2024 | Exor N.V. | 13GOld format | – | New | – | SEC |
| PHGKoninklijke Philips NV | May 16, 2024 | Exor N.V. | 13D/AOld format | – | – | – | SEC |
| NGNovagold Resources Inc | Mar 25, 2024 | Exor N.V. | 13GOld format | – | New | – | SEC |
| CLVTClarivate PLC | Mar 4, 2024 | Exor N.V. | 13D/AOld format | – | – | – | SEC |